Post by Harvard Innovation Labs

Meet 2025 President’s Innovation Challenge Finalist: Limax Biosciences Limax Biosciences, founded by Benjamin Freedman and David Mooney (Harvard John A. Paulson School of Engineering and Applied Sciences), is developing a next-generation hydrogel inspired by nature’s toughest adhesives to address bleeding-related complications in surgery. Designed to adhere to wet tissue surfaces—even a beating heart—Limax’s patented technology enables stronger, more reliable sealing for injuries inside and outside the body. By bridging the interface between tissues and technology, Limax Biosciences is reshaping how surgeons seal, heal, and deliver treatments.

Video Content